A novel conditional active biologic anti-EpCAM x anti-CD3 bispecific antibody with synergistic tumor selectivity for cancer immunotherapy

Volume 16, Issue 1, January-December 2024 .

Source: mAbs - March 6, 2024 Category: Biomedical Science Authors: Gerhard FreyAna Paula G. CugnettiHaizhen LiuCharles XingChristina WheelerHwai Wen ChangWilliam J. BoyleJay M. ShortResearch & Development, BioAtla Inc, San Diego, CA, USA Source Type: research